NDRA · NASDAQ
ENDRA Life Sciences (NDRA) Stock Price & Fundamentals
ENDRA Life Sciences (NDRA) closed at $255.84 on Oct 9, 2026, up 0.37% from the previous close of $254.89.
Share price, past year
1Y +10.53%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $255.84 |
| Sep 30, 2026 | $259.11 |
| Aug 31, 2026 | $258.91 |
| Jul 31, 2026 | $266.69 |
| Jun 30, 2026 | $273.30 |
| May 29, 2026 | $259.86 |
| Apr 30, 2026 | $272.87 |
| Mar 31, 2026 | $273.00 |
| Feb 27, 2026 | $267.66 |
| Jan 30, 2026 | $261.73 |
| Dec 31, 2025 | $241.63 |
| Nov 28, 2025 | $246.46 |
| Oct 31, 2025 | $237.84 |
Key statistics
- Market cap
- $383.72M
- P/E (TTM)
- —
- EPS (TTM)
- −$4.84
- Revenue (TTM)
- —
- Net income (TTM)
- −$5.92M
- Shares outstanding
- 1.5M
- Dividend yield
- —
- 52-week range
- $230.08 – $279.37
ENDRA Life Sciences's market cap is $383.72M, based on a share price of $255.84 and 1.5M shares outstanding as of Jun 30, 2026.
Financials
ENDRA Life Sciences reported revenue of $0.00 for fiscal 2020.
ENDRA Life Sciences reported a net loss of $7.03M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2020ended Dec 31, 2020 | $0.00 | — | −$11.73M | — | — | −$10.82M |
| FY2019ended Dec 31, 2019 | $0.00 | −100.0% | −$13.31M | — | — | −$8.63M |
| FY2018ended Dec 31, 2018 | $6.17K | −98.2% | −$9.80M | −158,669.6% | — | −$7.80M |
| FY2017ended Dec 31, 2017 | $351.62K | −31.8% | −$5.38M | −1,529.2% | — | −$3.31M |
| FY2016ended Dec 31, 2016 | $515.58K | — | −$2.78M | −538.3% | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q4 FY2019ended Dec 31, 2019 | $0.00 | — | — |
| Q3 FY2019ended Sep 30, 2019 | $0.00 | — | — |
| Q2 FY2019ended Jun 30, 2019 | $0.00 | — | — |
| Q1 FY2019ended Mar 31, 2019 | $0.00 | — | — |
| Q4 FY2018ended Dec 31, 2018 | $0.00 | — | — |
| Q3 FY2018ended Sep 30, 2018 | $0.00 | — | — |
| Q2 FY2018ended Jun 30, 2018 | $0.00 | — | — |
| Q1 FY2018ended Mar 31, 2018 | $6.17K | — | — |
Company profile
- Name
- ENDRA Life Sciences Inc.
- Ticker
- NDRA
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Electromedical & Electrotherapeutic Apparatus
- Headquarters
- 3600 Green Court, Suite 350, Ann Arbor, MI 48105
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001681682
Recent SEC filings
- Oct 1, 2026
- Aug 17, 2026
- Aug 14, 2026
- Jul 9, 2026
- Jun 26, 2026
- Jun 25, 2026
- May 28, 2026
- May 15, 2026
Frequently asked questions
What is ENDRA Life Sciences's stock price?
ENDRA Life Sciences (NDRA) closed at $255.84 on Oct 9, 2026, up 0.37% from the previous close of $254.89.
What is ENDRA Life Sciences's market cap?
ENDRA Life Sciences's market cap is $383.72M, based on a share price of $255.84 and 1.5M shares outstanding as of Jun 30, 2026.
How much revenue does ENDRA Life Sciences make?
ENDRA Life Sciences reported revenue of $0.00 for fiscal 2020.
Does ENDRA Life Sciences pay a dividend?
ENDRA Life Sciences's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from ENDRA Life Sciences Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures